2-(4-Fluorophenoxy)-N-[(4-methoxy-2-methylphenylcarbamoyl)methyl]acetamide

ID: ALA3317750

PubChem CID: 89717783

Max Phase: Preclinical

Molecular Formula: C18H19FN2O4

Molecular Weight: 346.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(NC(=O)CNC(=O)COc2ccc(F)cc2)c(C)c1

Standard InChI:  InChI=1S/C18H19FN2O4/c1-12-9-15(24-2)7-8-16(12)21-17(22)10-20-18(23)11-25-14-5-3-13(19)4-6-14/h3-9H,10-11H2,1-2H3,(H,20,23)(H,21,22)

Standard InChI Key:  CEVDRPUZPCFAOV-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
   11.9812   -6.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2721   -6.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9812   -5.4314    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.6903   -6.6572    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3993   -6.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3993   -5.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1043   -5.0228    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.6903   -5.0228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8134   -5.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5225   -5.0228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2275   -5.4314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2275   -6.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5225   -6.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8134   -6.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5225   -4.2056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9365   -6.6572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6456   -6.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5671   -6.2486    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.8580   -6.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8580   -7.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1531   -7.8830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4440   -7.4744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4440   -6.6572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1531   -6.2486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7349   -7.8830    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1  4  1  0
  6  7  1  0
  6  8  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
  9 14  2  0
 10 15  1  0
 16 17  1  0
 12 16  1  0
  7  9  1  0
  5  6  1  0
  4  5  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 19 24  2  0
 18 19  1  0
 22 25  1  0
  2 18  1  0
M  END

Associated Targets(Human)

SRR Tbio Serine racemase (249 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 346.36Molecular Weight (Monoisotopic): 346.1329AlogP: 2.28#Rotatable Bonds: 7
Polar Surface Area: 76.66Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.97CX Basic pKa: CX LogP: 2.12CX LogD: 2.12
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.81Np Likeness Score: -1.88

References

1. Mori H, Wada R, Li J, Ishimoto T, Mizuguchi M, Obita T, Gouda H, Hirono S, Toyooka N..  (2014)  In silico and pharmacological screenings identify novel serine racemase inhibitors.,  24  (16): [PMID:25066953] [10.1016/j.bmcl.2014.07.003]
2.  (2014)  Serine racemase inhibitor,